Tradestie Institutional Equity Comparison Engine

COCP vs STTK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

STTK Overall Edge

STTK Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Shattuck Labs, Inc. Common Stock (STTK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus STTK at N/M Forward P/E and 0.0% operating margin (-66.6% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
COCP N/M vs STTK N/M Fwd P/E
Growth & Margin Winner STTK
Op Margin -3063.6% vs 0.0% ยท YoY +26.9% vs -66.6%
Momentum & Technical Winner STTK
1Y -3.0% vs +147.8% ยท 52W Pos 19% vs 43%
Options & Structure Winner STTK
UNCLASSIFIED (N/A IV) vs BREAKDOWN (10th %ile IV)
COCP NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap $19.6M
1M Return -2.01%
1Y Return -2.96%
Forward P/E N/M
Unified AI Score
47.1 / 100 HOLD
Tech 51.0 Fund 48.0 Flow 50.0 Mom 54.0
STTK NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.56
-1.94% 1D
Market Cap $474.6M
1M Return -15.87%
1Y Return +147.83%
Forward P/E N/M
Unified AI Score
51.1 / 100 HOLD
Tech 48.0 Fund 58.0 Flow 63.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: COCP -2.96% STTK +147.83% Spread: +150.79 pp (STTK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period COCP Revenue STTK Revenue COCP Op. Margin STTK Op. Margin Margin Edge
FY2011 $10M N/A -30.6% N/A COCP
FY2019 $10M $10M -737.4% -253.5% STTK
FY2020 $0M $10M -476.0% -371.8% STTK
FY2021 N/A $30M N/A -150.8% STTK
FY2022 N/A $0M N/A -15848.0% STTK
FY2023 N/A $0M N/A -5549.6% STTK
FY2024 N/A $10M N/A -1408.3% STTK
FY2025 N/A $0M N/A -5150.8% STTK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: COCP (2) vs STTK (5)
Institutional Metric COCP STTK Criterion Row Winner
Market Capitalization Scale $19.6M $474.6M Larger Scale STTK
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +26.9% -66.6% Higher Growth COCP
Operating Margin (TTM) Profitability -3063.6% 0.0% Higher Margin STTK
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -311.7% -47.2% Higher ROE STTK
52-Week Range Position Momentum 19% ($1โ€“$2) 43% ($2โ€“$8) Stronger Trend STTK
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 54% Vol 1.48ฮฒ ยท 78% Vol Lower Realized Risk COCP
Unified Institutional Score Composite Signal 47.1 / 100 (HOLD) 51.1 / 100 (HOLD) Higher Composite STTK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full COCP vs STTK Buy Guide
COCP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
STTK BREAKDOWN
58d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live STTK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither COCP nor STTK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.